Description
Regadenoson is an adenosine A2A receptor agonist that displays vasodilatory activity. Regadenoson is clinically used in myocardial perfusion imaging.
Product Unit Size | Cost | Quantity | Stock |
---|
Regadenoson is an adenosine A2A receptor agonist that displays vasodilatory activity. Regadenoson is clinically used in myocardial perfusion imaging.
Cas No. | 313348-27-5 |
---|---|
Purity | ≥99% |
Formula | C15H18N8O5 |
Formula Wt. | 390.35 |
IUPAC Name | 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide |
Solubility | Soluble in DMSO, and methanol |
Appearance | White to off white powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Palani G, Ananthasubramaniam K. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Cardiol Rev. 2013 Jan-Feb;21(1):42-8. PMID: 22643345.
Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol. 2004 Jul 22;94(2A):33D-40D; discussion 40D-42D. PMID: 15261132.
Phenylamino pyridine; Abl, c-Kit, PDGFR, PP2A i...
Peptide; galanin antagonist.
Quinazoline; α1-adrenergic antagonist.
ITC, used as chiral agent.
c-MET and Ron inhibitor.
Catechol-type flavonoid.
BTK inhibitor.
Nucleoside (guanosine) analog; DNA chain termin...
Carnitine derivative, involved in energy homeos...
Benzimidazole; microtubule polymerization inhib...
Tankyrase inhibitor.
Mycotoxin; F1F0 ATP synthase inhibitor.
Sphingosine 1-phosphate antagonist.
RyR agonist, SIRT, telomerase, P2Y, GPCR inhibi...
Synthetic steroid hormone; glucocorticoid agoni...
Peptide, GLP-1 analog found in Heloderma; GLP-1...
SHP2 inhibitor
Endogenous glycoprotein hormone involved in red...
p110α and p110γ PI3K inhibitor.
Recombinant HIV glycoprotein antigen fragment.<...